Compare RLX & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLX | VCYT |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.1B |
| IPO Year | 2020 | 2013 |
| Metric | RLX | VCYT |
|---|---|---|
| Price | $1.94 | $59.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $2.50 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 2.7M | 1.5M |
| Earning Date | 05-15-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.75% | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | N/A | ★ 0.35 |
| Revenue | N/A | N/A |
| Revenue This Year | $55.89 | $13.76 |
| Revenue Next Year | $15.07 | $12.35 |
| P/E Ratio | ★ $28.09 | $167.80 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.76 | $22.61 |
| 52 Week High | $2.68 | $60.91 |
| Indicator | RLX | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 46.09 | 75.75 |
| Support Level | N/A | $31.13 |
| Resistance Level | $2.40 | N/A |
| Average True Range (ATR) | 0.08 | 2.49 |
| MACD | 0.00 | 0.53 |
| Stochastic Oscillator | 53.67 | 95.70 |
RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers. It has an integrated offline distribution and "Branded store plus" retail model tailored to China's e-vapor market.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).